Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation

Kidney International

Volumn 85, Issue 5, 2014, Pages 1068-1077

  Matsusaka, Taiji ^a   Niimura, Fumio ^a   Pastan, Ira ^b   Shintani, Ayumi ^c   Nishiyama, Akira ^d   Ichikawa, Iekuni ^c,e  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d KAGAWA UNIVERSITY   (Japan)

^e TOKAI UNIVERSITY   (Japan)

Author keywords

Glomerular filtration barrier; Nephrotic syndrome; Podocyte; Proteinuria; Renin angiotensin system

Indexed keywords

ALBUMIN; ANGIOTENSIN II; ANGIOTENSINOGEN; LIVER DERIVED ANGIOTENSINOGEN; MESSENGER RNA; UNCLASSIFIED DRUG; AGT PROTEIN, MOUSE; B3(FV)-PE38KDEL RECOMBINANT IMMUNOTOXIN; EXOTOXIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NEPHRIN; SODIUM;

AGT GENE; ALBUMIN URINE LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; GENE; GENE INACTIVATION; GLOMERULONEPHRITIS; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; KIDNEY INJURY; KIDNEY LEVEL; LIVER LEVEL; MOUSE; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; TISSUE LEVEL; URINARY EXCRETION; ALBUMINURIA; ANIMAL; CHEMICALLY INDUCED; DEFICIENCY; GENETICS; GENOTYPE; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY; TIME; UPREGULATION; URINE;

ALBUMINURIA; ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; EXOTOXINS; GENOTYPE; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; LIVER; MEMBRANE PROTEINS; MICE, KNOCKOUT; PHENOTYPE; PODOCYTES; RNA, MESSENGER; SODIUM; TIME FACTORS; UP-REGULATION;

EID: 84899736008     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.453     Document Type: Article

References (37)

1. Navar LG, Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens 2004; 13: 107-115.
2. Kobori H, Nangaku M, Navar LG et al. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
3. Pendergrass KD, Averill DB, Ferrario CM et al. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol 2006; 290: F1497-F1506.
4. Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol 2010; 31: 541-550.
5. Bader M, Ganten D. Update on tissue renin-angiotensin systems. J Mol Med (Berl) 2008; 86: 615-621.
6. Li J, Zhou C, Yu L et al. Renal protective effects of blocking the intrarenal renin-angiotensin system. Hypertens Res 1999; 22: 223-228.
7. Largo R, Gomez-Garre D, Soto K et al. Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999; 33: 732-739.
8. Takase O, Marumo T, Imai N et al. NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria. Kidney Int 2005; 68: 464-473.
9. Ruiz-Ortega M, Gonzalez S, Seron D et al. Ace inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 1995; 48: 1778-1791.
10. Ibrahim HN, Hostetter TH. The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol 1998; 9: 72-76.
11. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993; 265: F477-F486.
12. Hsieh TJ, Zhang SL, Filep JG et al. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002; 143: 2975-2985.
13. Singh R, Singh AK, Leehey DJ. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am J Physiol Renal Physiol 2005; 288: F1183-F1190.
14. Taniguchi M, Kim S, Zhan Y et al. Role of intrarenal angiotensinconverting enzyme in nephropathy of type II diabetic rats. Hypertens Res 2002; 25: 287-294.
15. Ichihara A, Hayashi M, Kaneshiro Y et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the ''handle'' region for nonproteolytic activation of prorenin. J Clin Invest 2004; 114: 1128-1135.
16. Zhuo JL, Li XC. Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells. J Renin Angiotensin Aldosterone Syst 2007; 8: 23-33.
17. Urata H. Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2000; 1: S35-S37.
18. Graciano ML, Cavaglieri Rde C, Delle H et al. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 2004; 15: 1805-1815.
19. Crackower MA, Sarao R, Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417: 822-828.
20. Niimura F, Okubo S, Fogo A et al. Temporal and spatial expression pattern of the angiotensinogen gene in mice and rats. Am J Physiol 1997; 272: R142-R147.
21. Pohl M, Kaminski H, Castrop H et al. Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 2010; 285: 41935-41946.
22. Terada Y, Tomita K, Nonoguchi H et al. PCR localization of angiotensin II receptor and angiotensinogen mrnas in rat kidney. Kidney Int 1993; 43: 1251-1259.
23. Matsusaka T, Niimura F, Shimizu A et al. Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 2012; 23: 1181-1189.
24. Matsusaka T, Xin J, Niwa S et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocytespecific injury. J Am Soc Nephrol 2005; 16: 1013-1023.
25. Kobori H, Ozawa Y, Suzaki Y et al. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 2005; 16: 2073-2080.
26. Gociman B, Rohrwasser A, Lantelme P et al. Expression of angiotensinogen in proximal tubule as a function of glomerular filtration rate. Kidney Int 2004; 65: 2153-2160.
27. Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 2001; 12: 431-439.
28. Schunkert H, Ingelfinger JR, Jacob H et al. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 1992; 263: E863-E869.
29. Navar LG, Satou R, Gonzalez-Villalobos RA. The increasing complexity of the intratubular renin-angiotensin system. J Am Soc Nephrol 2012; 23: 1130-1132.
30. Gonzalez-Villalobos RA, Seth DM, Satou R et al. Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol 2008; 295: F772-F779.
31. Schunkert H, Ingelfinger JR, Hirsch AT et al. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 1992; 90: 1523-1529.
32. van den Heuvel M, Batenburg WW, Jainandunsing S et al. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin- aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. J Hypertens 2011; 29: 2147-2155.
33. Nishiyama A, Konishi Y, Ohashi N et al. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant 2011; 26: 170-177.
34. Nakano D, Kobori H, Burford JL et al. Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol 2012; 23: 1847-1856.
35. Schulz A, Weiss J, Schlesener M et al. Development of overt proteinuria in the Munich Wistar Fromter rat is suppressed by replacement of chromosome 6 in a consomic rat strain. J Am Soc Nephrol 2007; 18: 113-121.
36. Ichikawa I, Rennke HG, Hoyer JR et al. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 1983; 71: 91-103.
37. Matsusaka T, Kobayashi K, Kon V et al. Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection. Am J Physiol Renal Physiol 2011; 300: F792-F800.